Please login (Members) to view content or
(Nonmembers) this article.
0
No votes yet
Letter

Response to "Nephrotoxicity: Evidence in Patients Receiving Cisplatin Therapy"

Mehdi Nematbakhsh
CJON 2018, 22(5), 477-478 DOI: 10.1188/18.CJON.477-478

An article by Duffy, Fitzgerald, Boyle, and Rohatgi (2018) was published in the April issue of the Clinical Journal of Oncology Nursing. Based on review, the authors suggested some clinical recommendations to protect the kidneys against cisplatin-induced nephrotoxicity, including hydration or supplementation of magnesium or mannitol during cisplatin administration. In addition to clinical findings, the related basic sciences data may be helpful in formulating treatment guidelines in cisplatin therapy. This letter will present several suggestions for future clinical studies based on laboratory findings.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or